Royalty Pharma plc (RPRX) — Net Income

Annual figures by fiscal year, from SEC filings.

2018: $1.38B2019: $2.35B2020: $975.04M2021: $619.73M2022: $42.83M2023: $1.13B2024: $858.98M2025: $770.95M$770.95M
2018Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$770.95M-10.2%
2024$858.98M-24.3%
2023$1.13B+2549.5%
2022$42.83M-93.1%
2021$619.73M-36.4%
2020$975.04M-58.5%
2019$2.35B+70.5%
2018$1.38B